Literature DB >> 8920767

Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?

H A Lan1, R B Zain, M Saitoh, Y Muramatsu, P Shrestha, M Mori.   

Abstract

The immunohistochemical expression of proliferating cell nuclear antigen (PCNA) and p53 was investigated in 9 cases of epithelial dysplasia and 38 cases of squamous cell carcinoma of the oral cavity. The intensity of immunoreactivity for each marker was assessed using a semiquantitative grading system, and was correlated with tumor differentiation, nuclear atypia and the patterns of invasive margins in the underlying connective tissue. PCNA expression, in dysplastic epithelium, was observed in the suprabasal and lower spinous layers; and the labeling grade and intensity of staining increased along with the degree of cellular atypia. In 2 cases of dysplasia, weak positive immunoreactivity for p53 could be seen in a few isolated cells of the basal layer. In squamous cell carcinoma, PCNA expression was correlated with the degree of tumor differentiation and nuclear atypia in well and moderately differentiated carcinoma, but not with the invasive pattern of tumor growth. Immunoreactivity for p53 was positive in 30 cases and showed a distribution pattern very similar to PCNA but with fewer positive cells. Three distinct categories of expression for PCNA and p53 were observed, among them a combination of intense reactivity for both markers was indicative of poor differentiation, higher nuclear atypia and more invasive growth of tumor cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920767

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Characterisation of the progression of azaserine-induced rat pancreatic adenocarcinoma by proliferative cell nuclear antigen, basement membrane laminin and trypsinogen immunohistochemistry.

Authors:  Krisztina Nagy; Zsolt Pálfia; Gábor Réz
Journal:  Histochem Cell Biol       Date:  2003-05-13       Impact factor: 4.304

2.  Proliferating Cell Nuclear Antigen in Premalignancy and Oral Squamous Cell Carcinoma.

Authors:  Chandrashekar Poosarla; Maya Ramesh; K Ramesh; Swetha Gudiseva; Sekar Bala; Murali Sundar
Journal:  J Clin Diagn Res       Date:  2015-06-01

Review 3.  The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.

Authors:  Shuangshuang Ma; Junsheng Yang; Jinpeng Li; Jinlong Song
Journal:  Tumour Biol       Date:  2015-12-17

4.  Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.

Authors:  Emily Ming-Chieh Lu; Jithendra Ratnayake; Alison Mary Rich
Journal:  BMC Oral Health       Date:  2019-10-31       Impact factor: 2.757

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.